Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 643,803 | 659,007 | 673,658 | 651,373 | 290,277 |
| Marketable Securities | 28,094 | 44,761 | 62,060 | 78,599 | 69,121 |
| Receivables | 30,189 | 9,975 | 8,452 | 8,628 | 8,933 |
| TOTAL | $720,083 | $717,163 | $748,970 | $741,456 | $371,344 |
| Non-Current Assets | |||||
| PPE Net | 128,829 | 129,880 | 129,476 | 126,643 | 122,591 |
| Investments And Advances | 10,587 | 10,506 | 10,506 | 16,767 | 39,204 |
| Other Non-Current Assets | 10,420 | 10,062 | 9,698 | 10,026 | 9,499 |
| TOTAL | $149,836 | $150,448 | $149,680 | $153,436 | $171,294 |
| Total Assets | $869,919 | $867,611 | $898,650 | $894,892 | $542,638 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,222 | 3,549 | 5,509 | 6,407 | 3,261 |
| Accrued Expenses | 49,492 | 62,859 | 63,781 | 54,117 | 48,534 |
| TOTAL | $90,559 | $83,342 | $85,960 | $68,498 | $59,774 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 37,845 | 16,934 | 16,670 | 7,974 | 7,979 |
| Other Non-Current Liabilities | 26,299 | 26,385 | 25,291 | 23,612 | 22,529 |
| TOTAL | $264,558 | $265,480 | $264,952 | $235,625 | $233,495 |
| Total Liabilities | $355,117 | $348,822 | $350,912 | $304,123 | $293,269 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,373 | 3,341 | 3,307 | 3,280 | 2,848 |
| Common Shares | 842 | 834 | 825 | 818 | 710 |
| Retained earnings | -694,224 | -670,803 | -630,657 | -573,823 | -536,086 |
| Other shareholders' equity | 16,660 | 15,649 | 17,476 | 17,662 | 17,884 |
| TOTAL | $514,802 | $518,789 | $547,738 | $590,769 | $249,369 |
| Total Liabilities And Equity | $869,919 | $867,611 | $898,650 | $894,892 | $542,638 |